Login
Résultat de la recherche (1-20 par 83)Download
|
Symbol
|
KYUADU | RMBQ5V | KZEHDU | KZFDDU | KZJVDU | RMBAIV | MBSTJB | MBUMJB | MBSPJB | PUIRCH | KZXVDU | ACMVSQ | ADAATQ | LAGLDU | LALBDU | RMAY9V | ADXETQ | LAUJDU | 1129BC | AEEBTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Lock-In Barrier Reverse Convertible | Lock-In Barrier Reverse Convertible | Lock-In Barrier Reverse Convertible | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Eli Lilly / Merck & Co. / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | AstraZeneca Plc / Eli Lilly & Co. / Merck & Co. Inc. | AstraZeneca Plc / Eli Lilly & Co. / Merck & Co. Inc. | AstraZeneca Plc / Eli Lilly & Co. / Merck & Co. Inc. | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
18.09.2026 | 17.11.2026 | 20.11.2026 | 30.11.2026 | 30.12.2026 | 30.12.2026 | 15.09.2026 | 15.09.2026 | 15.09.2026 | 17.09.2026 | 08.09.2026 | 23.11.2026 | 27.11.2026 | 07.12.2026 | 02.07.2027 | 14.01.2027 | 12.02.2027 | 01.03.2027 | 05.03.2027 | 08.12.2026 |
| Demande | - | 41,400 | 41,250 | - | 39,200 | 53,70 | - | - | - | 52,44 | - | 74,02 | 70,66 | - | - | 70,60 | 100,78 | 99,10 | 96,88 | 102,47 |
| Offre | - | - | 42,250 | - | - | - | - | - | - | - | - | - | - | - | - | - | 101,59 | 100,10 | 97,65 | 103,29 |
S'il vous plait attendre
Le push de données de prix a été désactivé en raison d'un timeout. S'il vous plaît cliquez sur "Actualiser la page" pour continuer.
Votre mémo (0)